We are live on ! Find out more
CNLM

CB PHARMA ACQUISISTION CORP SHS (CYM)
CNLM

Delisted

CNLM was delisted on the 8th of June, 2016.

Back to rankings

7 hedge funds and large institutions have $13.3M invested in CB PHARMA ACQUISISTION CORP SHS (CYM) in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more funds holding

Funds holding: 6 → 7 (+1)

12% more capital invested

Capital invested by funds: $11.9M → $13.3M (+$1.38M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KIM
Karpus Investment Management
New York
+$1.31M
2
TRCT
Tower Research Capital (TRC)
New York
+$805

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PAMP
1
Polar Asset Management Partners
Ontario, Canada
$5.47M – – –
AA
2
AQR Arbitrage
Connecticut
$3.47M – – –
WAM
3
Weiss Asset Management
Massachusetts
$2.67M – – –
KIM
4
Karpus Investment Management
New York
$1.3M +$1.31M +131,601 New
GCL
5
Glazer Capital LLC
New York
$228K – – –
YCM
6
Yakira Capital Management
Connecticut
$124K – – –
TRCT
7
Tower Research Capital (TRC)
New York
$1K +$805 +81 +426%

CNLM Hedge Fund Activity: Q3 2015 in Review

7 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in CB PHARMA ACQUISISTION CORP SHS (CYM) (CNLM) for Q3 2015, worth a combined $13.3M — up 12% from $11.9M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new CNLM positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Karpus Investment Management, opening a new position worth an estimated $1.31M.

  • 7 institutional investors held CB PHARMA ACQUISISTION CORP SHS (CYM) (CNLM) as of Q3 2015, up from 6 in Q2 2015.
  • Funds reported $13.3M of CB PHARMA ACQUISISTION CORP SHS (CYM) stock for Q3 2015, up 12% quarter-over-quarter.
  • 1 fund opened new CB PHARMA ACQUISISTION CORP SHS (CYM) positions in Q3 2015 and 0 closed out, a net change of +1 holder.
  • The largest CB PHARMA ACQUISISTION CORP SHS (CYM) buyer in Q3 2015 was Karpus Investment Management, an estimated $1.31M added.

Based on aggregated 13F filings for Q3 2015.